
Bayer US Finance LLC, founded in 2004 and based in Whippany, New Jersey, serves as a financing subsidiary of Bayer AG, one of the world's leading life science companies. The company provides a range of financial services, including debt financing solutions and capital management, supporting its parent company’s strategic objectives across various sectors, including pharmaceuticals and agriculture.
Bond Name | Country | Maturity | Coupon(%) | |
---|---|---|---|---|
BAYNGR 6.13% 2026-11-21 USDBayer US Finance LLC | United States | 2026-11-21 | 6.125 | 4.88 |
BAYNGR 6.13% 2026-11-21 USDBayer US Finance LLC | United States | 2026-11-21 | 6.125 | 4.88 |
BAYNGR 6.25% 2029-01-21 USDBayer US Finance LLC | United States | 2029-01-21 | 6.250 | 4.70 |
BAYNGR 6.25% 2029-01-21 USDBayer US Finance LLC | United States | 2029-01-21 | 6.250 | 4.73 |
BAYNGR 6.38% 2030-11-21 USDBayer US Finance LLC | United States | 2030-11-21 | 6.375 | 4.95 |
BAYNGR 6.38% 2030-11-21 USDBayer US Finance LLC | United States | 2030-11-21 | 6.375 | 4.70 |
BAYNGR 6.50% 2033-11-21 USDBayer US Finance LLC | United States | 2033-11-21 | 6.500 | 5.43 |
BAYNGR 6.50% 2033-11-21 USDBayer US Finance LLC | United States | 2033-11-21 | 6.500 | 5.43 |
BAYNGR 6.88% 2053-11-21 USDBayer US Finance LLC | United States | 2053-11-21 | 6.875 | 6.35 |
BAYNGR 6.88% 2053-11-21 USDBayer US Finance LLC | United States | 2053-11-21 | 6.875 | 6.37 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Bayer US Finance LLC began issuing bonds shortly after its inception, with its first notable issuance occurring in 2005 as part of a larger financing strategy for corporate acquisitions. In recent years, the company has issued bonds with varying maturities, including a significant 10-year bond in 2020 which garnered attention due to its competitive yield versus industry benchmarks. Currently, Bayer US Finance LLC's bonds offer yields that align closely with, or slightly outperform, the market average, and the company continually explores innovative bond structures to enhance liquidity and investor interest.